Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2021
Pharma News, 2021
EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU
COVID-19 Vaccine AstraZeneca is now authorised across the EU.
Colchicine may have therapeutic potential against COVID-19
Against the sheer scale of morbidity and death due to the ongoing coronavirus disease 2019 (COVID-19) pandemic, the urgency of identifying drugs and other measures that reduce these adverse ou...
Anticoagulant drug heparin targets coronavirus spike protein and could be repurposed to treat COVID-19
An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the SARS-Cov2 vir...
AZ/Daiichi Sankyo’s antibody drug conjugates prove promising in early trials
AstraZeneca (AZ) and Daiichi Sankyo have posted new data from Phase I/II trials evaluating their respective antibody drug conjugates (ADCs) Enhertu (trastuzumab deruxtecan) and...
J&J vaccine adds to COVID-19 armoury with 66% global trial efficacy
(Reuters) - Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against multiple variants, giving health offi...
Exclusive: Sinopharm-led consortium plans $3.3 billion take-private of HK-listed China TCM
HONG KONG (Reuters) - A consortium led by state-owned pharma giant Sinopharm plans to take private China Traditional Chinese Medicine Holdings in a deal that would value the firm at at least $...
Lilly and Asahi Kasei Pharma Announce License Agreement for Chronic Pain Drug Candidate
INDIANAPOLIS, IN, USA and TOKYO, Japan - January 28, 2021.
Nasal spray developed in Turkey kills coronavirus in 1 minute
The COVID-19 pandemic, which has now affected over 100 million people across the world, has put many microbiologists to work to find viable solutions.
Prilenia Enrolls First Subject in Europe in its PROOF-HD Phase 3 Clinical Trial for Huntington’s Disease
NAARDEN, The Netherlands - January 28, 2021.
REGEN-COV™ Antibody Cocktail Is Active Against SARS-CoV-2 Variants First Identified in the UK and South Africa
TARRYTOWN, NY, USA I January 27, 2021 I Regeneron Pharmaceuticals, Inc.
PharmaMar says paper in journal Science confirms drug's efficacy
MADRID (Reuters) - Spanish pharmaceutical company PharmaMar said on Tuesday that peer review journal Science has published a paper that confirms its drug Plitidepsin has a “potent preclinica...
Second-generation double antibody protects from SARS-CoV-2 and its tested variants
The Institute for Research in Biomedicine (IRB; Bellinzona, Switzerland), affiliated to the Università della Svizzera italiana (USI) developed a second-generation 'double antibody...
69
70
71
72
73
74
75
76
77
